Concern is growing among public health experts that anti-vaccine sentiments within federal and state governments may derail ...

Here is why it could be a smart buy now. Not every stock needs to be a millionaire-maker. Sometimes, slow and steady can win ...

The delay dovetails with moves by Republican lawmakers in at least seven states to ban or limit mRNA vaccines. Some, according to KFF Health News, are also pressing regulators to revoke federal ...

As the Salt River Pima-Maricopa Indian Community unveiled a new COVD memorial, tribal leaders around Arizona look back at the pandemic response.

These five well-known dividend stocks were beaten down in the recent selling but will remain attractive long after the tariff ...

Interactive investor said it recorded its highest-ever trading volumes on Monday, with investors buying more than selling.

Pfizer stock fell to the lowest closing price since 2012, putting its yield near 8%, after cautious comments from a UBS ...

Laboratory-confirmed and diagnosed COVID-19 cases and COVID-19 outbreaks must still be reported to the Vermont Department of ...

UBS analyst Trung Huynh lowered the firm’s price target on Pfizer (PFE) to $24 from $28 and keeps a Neutral rating on the shares. The firm says ...

Goldman Sachs downgraded Pfizer (PFE) to Neutral from Buy with a price target of $25, down from $32, after assuming coverage of the name. The ...